Evidence map›Paper›PMID 24217246›Full record

ArticleThe Journal of biological chemistry2013

Frataxin directly stimulates mitochondrial cysteine desulfurase by exposing substrate-binding sites, and a mutant Fe-S cluster scaffold protein with frataxin-bypassing ability acts similarly.

Alok Pandey, Donna M Gordon, Jayashree Pain, Timothy L Stemmler, Andrew Dancis, Debkumar Pain

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cardiac Involvement in Mitochondrial Disorders.Current heart failure reports · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Future Prospects of Gene Therapy for Friedreich's Ataxia.International journal of molecular sciences · 2021
    Review
  18. Biogenesis of Iron-Sulfur Clusters and Their Role in DNA Metabolism.Frontiers in cell and developmental biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Alok PandeyFrom the Department of Pharmacology and Physiology, New Jersey Medical School, Rutgers University, Newark, New Jersey 07101.
Donna M Gordon
Jayashree Pain
Timothy L Stemmler
Andrew Dancis
Debkumar Pain
Rutgers, The State University of New Jersey · USUniversity of Pennsylvania · USWayne State University · US

Funding

Structural Insights into the Function of FrataxinR01DK068139 · NIDDK · WAYNE STATE UNIVERSITY · PI STEMMLER, TIMOTHY LOUIS · 2005 to 2015
$3.5M
Biochemistry and genetics of iron transport in mitochondria and related processesR37DK053953 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DANCIS, ANDREW B. · 2008 to 2015
$2.9M
Mitochondrial aconitase: Fe-S cluster biogenesis and interaction with mtDNAR01AG030504 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PAIN, DEBKUMAR · 2008 to 2012
$1.6M
NIA NIH HHS R01 AG030504NIA NIH HHS R01AG030504NIDDK NIH HHS R01 DK068139NIDDK NIH HHS R01DK068139NIDDK NIH HHS R37 DK053953NIDDK NIH HHS R37DK053953
6 · The paper itself

Abstract

For iron-sulfur (Fe-S) cluster synthesis in mitochondria, the sulfur is derived from the amino acid cysteine by the cysteine desulfurase activity of Nfs1. The enzyme binds the substrate cysteine in the pyridoxal phosphate-containing site, and a persulfide is formed on the active site cysteine in a manner depending on the accessory protein Isd11. The persulfide is then transferred to the scaffold Isu, where it combines with iron to form the Fe-S cluster intermediate. Frataxin is implicated in the process, although it is unclear where and how, and deficiency causes Friedreich ataxia. Using purified proteins and isolated mitochondria, we show here that the yeast frataxin homolog (Yfh1) directly and specifically stimulates cysteine binding to Nfs1 by exposing substrate-binding sites. This novel function of frataxin does not require iron, Isu1, or Isd11. Once bound to Nfs1, the substrate cysteine is the source of the Nfs1 persulfide, but this step is independent of frataxin and strictly dependent on Isd11. Recently, a point mutation in Isu1 was found to bypass many frataxin functions. The data presented here show that the Isu1 suppressor mimics the frataxin effects on Nfs1, explaining the bypassing activity. We propose a regulatory mechanism for the Nfs1 persulfide-forming activity. Specifically, at least two separate conformational changes must occur in the enzyme for optimum activity as follows: one is mediated by frataxin interaction that exposes the "buried" substrate-binding sites, and the other is mediated by Isd11 interaction that brings the bound substrate cysteine and the active site cysteine in proximity for persulfide formation.

Indexed as

MutationBinding SitesCarbon-Sulfur LyasesCysteineFrataxinHumansIron-Binding ProteinsIron-Regulatory ProteinsIron-Sulfur ProteinsMitochondrial ProteinsModels, BiologicalProtein BindingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSulfidesSulfurtransferasesCarbon-Sulfur LyasesCysteineFrataxinIron-Binding ProteinsIron-Regulatory ProteinsIron-Sulfur ProteinsISCA1 protein, humanIsd11 protein, S cerevisiaeISU1 protein, S cerevisiaeLYRM4 protein, humanMitochondrial ProteinsNFS1 protein, humanNFS1 protein, S cerevisiaepersulfidesSaccharomyces cerevisiae ProteinsSulfidesSulfurtransferasesIron-Sulfur ProteinMetal HomeostasisMetalsMitochondriaMitochondrial MetabolismPyridoxal PhosphateSulfurYeast

Identifiers

PMID24217246
PMCPMC3873537
OpenAlexW1983469428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.